Table IV.
Multivariate analysis of the overall survival rate of CCC patients.
| Parameters/categories | HR (95% CI) | P-value |
|---|---|---|
| HOXD10 expression | ||
| Negative | 0.341 (0.139–0.838) | 0.019a |
| Positive | ||
| RHOC expression | ||
| Negative | 1.744 (0.691–4.402) | 0.239 |
| Positive | ||
| TNM stage | ||
| I-II | 2.923 (1.210–7.064) | 0.017a |
| III-IV | ||
| Lymph node metastasis | ||
| Negative | 1.311 (0.713–2.411) | 0.383 |
| Positive | ||
| Histological grade | ||
| G1–G2 | 1.215 (0.646–2.284) | 0.545 |
| G3 |
a
Statistically significant. HR, hazard ratio; G1, well-differentiated; G2, moderately-differentiated; G3, poorly-differentiated; CCC, cholangiocellular carcinoma.